CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction

Cancer immunology is based upon boosting the body’s own immune system to vanquish malignancies. It is among the fastest growing areas of oncology res2016_02_23_human_t_cell_nihearch. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells – one of the immune system’s primary weapons – to treat three different types of blood cancer that often defy existing therapies.

Experimental cellular-immunotherapy may boost body’s ability to find and destroy specific cancers (click to continue reading)

Leave a Reply